Results 291 to 300 of about 378,823 (394)
Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study
Allergy. European Journal of Allergy and Clinical Immunology, 2018 J. Bousquet, S. Arnavielhe, A. Bedbrook, G. Alexis-Alexandre, M. Eerd, R. Murray, G. W. Canonica, M. Illario, E. Menditto, G. Passalacqua, C. Stellato, M. Triggiani, P. Carreiro‐Martins, J. Fonseca, M. M. Almeida, L. Nogueira-Silva, A. Pereira, A. T. Bom, I. Bossé, D. Caimmi, P. Demoly, P. Devillier, J. Fontaine, J. Just, G. Onorato, M. Kowalski, P. Kuna, B. Samoliński, Josep M. Antó, J. Mullol, A. Valero, P. Tomazic, K. Bergmann, T. Keil, T. Keil, L. Klimek, R. Mösgues, S. Shamai, T. Zuberbier, E. Murphy, Peter McDowall, D. Price, D. Ryan, A. Sheikh, N. Chavannes, W. Fokkens, V. Kvedarienė, A. Valiulis, A. Valiulis, C. Bachert, P. Hellings, I. Kull, E. Mélen, M. Wickman, C. Bindslev‐Jensen, E. Eller, T. Haahtela, E. Valovirta, N. Papadopoulos, N. Papadopoulos, I. Annesi-Maesano, M. Bewick, S. Bosnic‐Anticevich, Á. Cruz, G. Vries, B. Gemicioğlu, D. Larenas-Linnemann, D. Laune, E. Mathieu‐Dupas, R. O’Hehir, F. Portejoie, V. Siroux, O. Spranger, O. Vandenplas, A. Yorgancioglu +74 moresemanticscholar +1 more sourceLong‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria
Allergy, EarlyView.Ligelizumab re‐treatment in CSU patients showed sustained efficacy and tolerability. Over 50% achieved symptom control (UAS7 ≤ 6) by Week 12; benefits maintained through Week 52. No new safety signals observed; aligns with prior PEARL trial outcomes. CSU, chronic spontaneous urticaria; mg, milligram; q4w, every 4 weeks; UAS, urticaria activity score ...Ana M. Gimenez‐Arnau, Marcus Maurer, Adam Reich, Chia‐Yu Chu, Diana Deleanu, Gordon Sussman, Jorge Sanchez, Knut Brockow, Koremasa Hayama, Michihiro Hide, Mohamed Denguezli, Raisa Meshkova, Roberta F. J. Criado, Sarbjit Saini, Solange Valle, Eva Hua, Pengpeng Wang, Alis Burciu, Isabelle Indermuehle, Vineeth Varanasi, Yolandi Joubert, Thomas Severin, Manmath Patekar +22 morewiley +1 more sourceEAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention
Allergy, EarlyView.ABSTRACT
The allergy and asthma epidemic in urban societies following World War II is mostly caused by changes in the environment, diet and lifestyle. Disconnection of urban populations from the wider environment has reduced the protective factors building up immunological resilience.Tari Haahtela, Liam O'Mahony, Claudia Traidl‐Hoffmann, Mubeccel Akdis, Ozlem Ceylan, Panagiotis Chaslaridis, Athanasios Damialis, Stefano Del Giacco, Antti Lauerma, Kari C. Nadeau, Inês Paciência, Isabella Pali‐Schöll, Oscar Palomares, Harald Renz, Jurgen Schwarze, Marilyn Urrutia‐Pereira, Carina Venter, Donata Vercelli, Tonya Winders, Cezmi A. Akdis, Marek Jutel, Ioana Agache +21 morewiley +1 more sourceA Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report
Allergy, EarlyView.ABSTRACT
The European Academy of Allergy and Clinical Immunology (EAACI) established a Task Force to assess the existing data on the relationship between eosinophilic esophagitis (EoE) and allergen immunotherapy (AIT). This systematic review and meta‐analysis aimed to study the incidence of confirmed EoE, developing as a side effect of AIT to food or ...Carlo Maria Rossi, Ingrid Terreehorst, Evaggelia Apostolidou, Martina Votto, Arzu Bakirtas, Antonella Cianferroni, George N. Konstantinou, Katerina Pantavou, Dario Antolin‐Amerigo, Enrico Heffler, Alberto Alvarez‐Perea, Montserrat Fernandez‐Rivas, Georgios K. Nikolopoulos, Oliver Pfaar, Constantinos Pitsios +14 morewiley +1 more source
